SVETLANA ZAHAROVA: Open Payments
NPI 1154373652 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 23 payments from 10 companies in 2025. Trend: 2023 $928 · 2024 $1,140 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $269 |
| Boston Scientific Corporation | 2 | $128 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Novo Nordisk Inc | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: ELIQUIS, WATCHMAN Access System, CAMZYOS, Wegovy, VERQUVO, LEQVIO, LifeVest, ONPATTRO.
Industry payments across WI — which companies pay providers there.
